Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Sep 28;11(19):5740.
doi: 10.3390/jcm11195740.

Atrial Fibrillation Detected by Implantable Monitor in Embolic Stroke of Undetermined Source: A New Clinical Entity

Salomé Snyman  1 , Elena Seder  2 , Marc David-Muller  2 , Victor Klein  2 , Emilie Doche  1   3 , Laurent Suissa  1   3   4 , Jean-Claude Deharo  2   3   4 , Emmanuelle Robinet-Borgomano  1 , Baptiste Maille  2   3
Affiliations

Atrial Fibrillation Detected by Implantable Monitor in Embolic Stroke of Undetermined Source: A New Clinical Entity

Salomé Snyman et al. J Clin Med. .

Abstract

Background: High incidence of covert paroxysmal atrial fibrillation (CPAF) detected by an implantable cardiac monitor (ICM) is expected in embolic stroke of undetermined source (ESUS) patients. This study aimed to determine the CPAF rate in an ESUS cohort using ICMs and compare stroke characteristics of patients with CPAF to those with known or inpatient-diagnosed AF (KIDAF).

Methods: ESUS patients with ICMs were enrolled. ESUS diagnosis was defined as a non-lacunar stroke in the absence of symptomatic atherosclerotic stenosis (≥50%), no major-risk cardioembolic source, and no other specific cause. ESUS characteristics of patients with CPAF were compared to ESUS patients without CPAF and to KIDAF stroke patients.

Results: During the median follow-up of 476 (371-615) days, CPAF was newly detected in 38/163 (23.31%) patients within 236 (115.50-510.75) days after the stroke. CPAF was independently associated to older age, coronaropathy, left atrial dilation, and atrial hyperexcitability, but not to stroke severity. Compared to KIDAF strokes, ESUS with CPAF had lower rates of proximal occlusion leading to milder clinical severity (NIHSS: 3.00 (1.00-8.25) vs. 14.50 (6.00-21.00)).

Conclusions: Our study revealed a high proportion of CPAF in ESUS. We highlight that CPAF is a distinct clinical entity compared to KIDAF based on differences in stroke characteristics and AF diagnosis temporality.

Keywords: ESUS; atrial fibrillation; cardiac monitoring; stroke; stroke prevention.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Time from ischemic stroke to CPAF diagnosis in ESUS using ICM.
Figure 2
Figure 2
AF diagnosis modalities for KIDAF.
Figure 3
Figure 3
Violin representation of clinical stroke severity (NIHSS) according to CPAF and KIDAF patients.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Hart R.G., Diener H.-C., Coutts S.B., Easton J.D., Granger C.B., O’Donnell M.J., Sacco R.L., Connolly S.J., Cryptogenic Stroke/ESUS International Working Group Embolic strokes of undetermined source: The case for a new clinical construct. Lancet Neurol. 2014;13:429–438. doi: 10.1016/S1474-4422(13)70310-7. - DOI - PubMed
    1. Ntaios G. Embolic Stroke of Undetermined Source: JACC Review Topic of the Week. J. Am. Coll. Cardiol. 2020;75:333–340. doi: 10.1016/j.jacc.2019.11.024. - DOI - PubMed
    1. Hart R.G., Sharma M., Mundl H., Kasner S.E., Bangdiwala S.I., Berkowitz S.D., Swaminathan B., Lavados P., Wang Y., Wang Y., et al. Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source. N. Engl. J. Med. 2018;378:2191–2201. doi: 10.1056/NEJMoa1802686. - DOI - PubMed
    1. Diener H.-C., Sacco R.L., Easton J.D., Granger C.B., Bernstein R.A., Uchiyama S., Kreuzer J., Cronin L., Cotton D., Grauer C., et al. Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source. N. Engl. J. Med. 2019;380:1906–1917. doi: 10.1056/NEJMoa1813959. - DOI - PubMed
    1. Sposato A.L., Cipriano E.L., Saposnik G., Vargas E.R., Riccio P.M., Hachinski V. Diagnosis of atrial fibrillation after stroke and transient ischaemic attack: A systematic review and meta-analysis. Lancet Neurol. 2015;14:377–387. doi: 10.1016/S1474-4422(15)70027-X. - DOI - PubMed

LinkOut - more resources